Cargando…
Standardization and quality assessment for clinical grade mesenchymal stem cells from human adipose tissue
BACKGROUND: Mesenchymal stem cells have immense potential in stem cell-based therapies, however there is a pre-requisite to develop a curative cell dose. Adipose tissue-derived mesenchymal stem cells are promising mainly due to their potential abundance, immunomodulatory effect and remarkable differ...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Hematologia e Hemoterapia
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371406/ https://www.ncbi.nlm.nih.gov/pubmed/30793099 http://dx.doi.org/10.1016/j.htct.2018.05.001 |
_version_ | 1783394532936646656 |
---|---|
author | Debnath, Tanya Chelluri, Lakshmi Kiran |
author_facet | Debnath, Tanya Chelluri, Lakshmi Kiran |
author_sort | Debnath, Tanya |
collection | PubMed |
description | BACKGROUND: Mesenchymal stem cells have immense potential in stem cell-based therapies, however there is a pre-requisite to develop a curative cell dose. Adipose tissue-derived mesenchymal stem cells are promising mainly due to their potential abundance, immunomodulatory effect and remarkable differentiation potential. Nevertheless, senescence may develop during their in vitro expansion due to the incidence of genetic instability. Hence, it is important to attain an ideal balance between mesenchymal stem cell growth, quality and genetic integrity before their clinical use. METHODS: Stromal vascular fraction was obtained from omentum tissue of patients undergoing liposuction procedures for morbid obesity. This study standardized a closed system protocol which can be utilized for clinical grade stem cell derivation. Stages of cell growth and characterization of human adipose tissue-derived mesenchymal stem cells were also assessed along with the chromosomal stability in these in vitro cultures. RESULTS: Human adipose tissue-derived mesenchymal stem cells maintained their spindle-shaped morphology and were able to proliferate and renew, confirming their suitability for in vitro cultivation and generate clinical grade mesenchymal stem cells. Immunophenotyping indicates that the cells expressed cluster of differentiation (CD)73/CD90/CD105, mesenchymal stem-cell markers, while lacked CD34/CD45/ Human Leukocyte antigen-antigen D related (HLA-DR) expression (hematopoietic cell markers). A cell cycle study demonstrated growth kinetics under in vitro culture conditions. Human adipose tissue derived mesenchymal stem cells expressed normal cell karyotype by chromosomal G-banding indicating their genetic stability at Passage 5. Mesenchymal stem cells also demonstrated trilineage differentiation. CONCLUSIONS: Availability of adipose tissue in abundance is a major advantage for clinical applications. Furthermore, detailed characterization of human adipose tissue-derived mesenchymal stem cells, their genomic stability and differentiation potential from stromal vascular fraction of human adipose tissue would help assist in tissue regeneration and repair. |
format | Online Article Text |
id | pubmed-6371406 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Sociedade Brasileira de Hematologia e Hemoterapia |
record_format | MEDLINE/PubMed |
spelling | pubmed-63714062019-02-21 Standardization and quality assessment for clinical grade mesenchymal stem cells from human adipose tissue Debnath, Tanya Chelluri, Lakshmi Kiran Hematol Transfus Cell Ther Original Article BACKGROUND: Mesenchymal stem cells have immense potential in stem cell-based therapies, however there is a pre-requisite to develop a curative cell dose. Adipose tissue-derived mesenchymal stem cells are promising mainly due to their potential abundance, immunomodulatory effect and remarkable differentiation potential. Nevertheless, senescence may develop during their in vitro expansion due to the incidence of genetic instability. Hence, it is important to attain an ideal balance between mesenchymal stem cell growth, quality and genetic integrity before their clinical use. METHODS: Stromal vascular fraction was obtained from omentum tissue of patients undergoing liposuction procedures for morbid obesity. This study standardized a closed system protocol which can be utilized for clinical grade stem cell derivation. Stages of cell growth and characterization of human adipose tissue-derived mesenchymal stem cells were also assessed along with the chromosomal stability in these in vitro cultures. RESULTS: Human adipose tissue-derived mesenchymal stem cells maintained their spindle-shaped morphology and were able to proliferate and renew, confirming their suitability for in vitro cultivation and generate clinical grade mesenchymal stem cells. Immunophenotyping indicates that the cells expressed cluster of differentiation (CD)73/CD90/CD105, mesenchymal stem-cell markers, while lacked CD34/CD45/ Human Leukocyte antigen-antigen D related (HLA-DR) expression (hematopoietic cell markers). A cell cycle study demonstrated growth kinetics under in vitro culture conditions. Human adipose tissue derived mesenchymal stem cells expressed normal cell karyotype by chromosomal G-banding indicating their genetic stability at Passage 5. Mesenchymal stem cells also demonstrated trilineage differentiation. CONCLUSIONS: Availability of adipose tissue in abundance is a major advantage for clinical applications. Furthermore, detailed characterization of human adipose tissue-derived mesenchymal stem cells, their genomic stability and differentiation potential from stromal vascular fraction of human adipose tissue would help assist in tissue regeneration and repair. Sociedade Brasileira de Hematologia e Hemoterapia 2019 2018-06-19 /pmc/articles/PMC6371406/ /pubmed/30793099 http://dx.doi.org/10.1016/j.htct.2018.05.001 Text en © 2018 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Debnath, Tanya Chelluri, Lakshmi Kiran Standardization and quality assessment for clinical grade mesenchymal stem cells from human adipose tissue |
title | Standardization and quality assessment for clinical grade mesenchymal stem cells from human adipose tissue |
title_full | Standardization and quality assessment for clinical grade mesenchymal stem cells from human adipose tissue |
title_fullStr | Standardization and quality assessment for clinical grade mesenchymal stem cells from human adipose tissue |
title_full_unstemmed | Standardization and quality assessment for clinical grade mesenchymal stem cells from human adipose tissue |
title_short | Standardization and quality assessment for clinical grade mesenchymal stem cells from human adipose tissue |
title_sort | standardization and quality assessment for clinical grade mesenchymal stem cells from human adipose tissue |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371406/ https://www.ncbi.nlm.nih.gov/pubmed/30793099 http://dx.doi.org/10.1016/j.htct.2018.05.001 |
work_keys_str_mv | AT debnathtanya standardizationandqualityassessmentforclinicalgrademesenchymalstemcellsfromhumanadiposetissue AT chellurilakshmikiran standardizationandqualityassessmentforclinicalgrademesenchymalstemcellsfromhumanadiposetissue |